Risk factors for nonadherence to antihypertensive treatment P Gupta, P Patel, B Štrauch, FY Lai, A Akbarov, V Marešová, CMJ White, ... Hypertension 69 (6), 1113-1120, 2017 | 285 | 2017 |
Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence P Gupta, P Patel, B Štrauch, FY Lai, A Akbarov, GS Gulsin, A Beech, ... Hypertension 70 (5), 1042-1048, 2017 | 224 | 2017 |
Diabetic cardiomyopathy: prevalence, determinants and potential treatments GS Gulsin, L Athithan, GP McCann Therapeutic advances in endocrinology and metabolism 10, 2042018819834869, 2019 | 136 | 2019 |
Relationship between focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection fraction P Kanagala, ASH Cheng, A Singh, JN Khan, GS Gulsin, P Patel, P Gupta, ... JACC: Cardiovascular Imaging 12 (11 Part 2), 2291-2301, 2019 | 113 | 2019 |
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date L Athithan, GS Gulsin, GP McCann, E Levelt World journal of diabetes 10 (10), 490, 2019 | 109 | 2019 |
Mechanisms in endocrinology: diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review E Levelt, G Gulsin, S Neubauer, GP McCann European journal of endocrinology 178 (4), R127-R139, 2018 | 96 | 2018 |
Effects of low-energy diet or exercise on cardiovascular function in working-age adults with type 2 diabetes: a prospective, randomized, open-label, blinded end point trial GS Gulsin, DJ Swarbrick, L Athithan, EM Brady, J Henson, E Baldry, ... Diabetes care 43 (6), 1300-1310, 2020 | 82 | 2020 |
Cardiovascular magnetic resonance in the evaluation of heart valve disease GS Gulsin, A Singh, GP McCann BMC medical imaging 17, 1-14, 2017 | 65 | 2017 |
Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management A Al-Hussaini, AM Abdelaty, GS Gulsin, JR Arnold, M Garcia-Guimaraes, ... European Heart Journal 41 (23), 2197-2205, 2020 | 55 | 2020 |
Relation of aortic stiffness to left ventricular remodeling in younger adults with type 2 diabetes GS Gulsin, DJ Swarbrick, WH Hunt, E Levelt, MPM Graham-Brown, ... Diabetes 67 (7), 1395-1400, 2018 | 50 | 2018 |
Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction JR Arnold, P Kanagala, CA Budgeon, M Jerosch-Herold, GS Gulsin, ... Cardiovascular Imaging 15 (6), 1001-1011, 2022 | 48 | 2022 |
Native aortic valve disease progression and bioprosthetic valve degeneration in patients with transcatheter aortic valve implantation J Kwiecinski, E Tzolos, TRG Cartlidge, A Fletcher, MK Doris, R Bing, ... Circulation 144 (17), 1396-1408, 2021 | 47 | 2021 |
Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study A Salzano, MZ Israr, Y Yazaki, LM Heaney, P Kanagala, A Singh, ... European journal of preventive cardiology 27 (19), 2159-2162, 2020 | 46 | 2020 |
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction P Kanagala, JR Arnold, ASH Cheng, A Singh, JN Khan, GS Gulsin, ... The international journal of cardiovascular imaging 36, 101-110, 2020 | 45 | 2020 |
Characterizing heart failure with preserved and reduced ejection fraction: an imaging and plasma biomarker approach P Kanagala, JR Arnold, A Singh, DCS Chan, ASH Cheng, JN Khan, ... PloS one 15 (4), e0232280, 2020 | 44 | 2020 |
Cardiovascular determinants of aerobic exercise capacity in adults with type 2 diabetes GS Gulsin, J Henson, EM Brady, JA Sargeant, EG Wilmot, L Athithan, ... Diabetes Care 43 (9), 2248-2256, 2020 | 39 | 2020 |
The assessment of coronary artery disease in patients with end-stage renal disease FE Poli, GS Gulsin, GP McCann, JO Burton, MP Graham-Brown Clinical Kidney Journal 12 (5), 721-734, 2019 | 35 | 2019 |
Epicardial adipose tissue in obesity-related cardiac dysfunction SL Ayton, GS Gulsin, GP McCann, AJ Moss Heart 108 (5), 339-344, 2022 | 34 | 2022 |
Leaflet and neoskirt height in transcatheter heart valves: implications for repeat procedures and coronary access M Akodad, S Sellers, GS Gulsin, G Tzimas, U Landes, AG Chatfield, ... Cardiovascular Interventions 14 (20), 2298-2300, 2021 | 32 | 2021 |
MRI and CT coronary angiography in survivors of COVID-19 T Singh, TA Kite, SS Joshi, NB Spath, L Kershaw, A Baker, H Jordan, ... Heart 108 (1), 46-53, 2022 | 29 | 2022 |